SCHEMBL4919677

SCHEMBL4919677

Cc1c(C(=O)NCc2ccc(OCF)cc2)sc2ccc(Cl)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 2/20 0.46
PPARA Q07869 2/20 0.46
PPARG P37231 1/20 0.46
CHRM4 P08173 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
MAPT P10636 4/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
CNR1 P21554 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
S1PR1 P21453 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14270791 0.87 PPARA (0.49) PPARDPPARAPPARGCHRM4SMN1; SMN2
SCHEMBL4917272 0.78 CCR1 (0.45) PPARDPPARAPPARGCHRM4MAPT
SCHEMBL4920602 0.77 MAPT (0.53) PPARDPPARAPPARGSMN1; SMN2MAPT
SCHEMBL6360877 0.75 L3MBTL1 (0.51) PPARDPPARAPPARGSMN1; SMN2MAPT
SCHEMBL3133584 0.74 OGG1 (0.52) PPARDPPARAPPARGSMN1; SMN2MAPT
SCHEMBL4615033 0.73 PPARG (0.65) PPARDPPARAPPARGMAPT
SCHEMBL4614236 0.73 PPARG (0.52) PPARDPPARAPPARGSMN1; SMN2MAPT
SCHEMBL4921770 0.73 PFKFB3 (0.43) SMN1; SMN2MAPTNPC1LMNARAB9A
SCHEMBL4615668 0.73 PPARG (0.65) PPARDPPARAPPARGCXCR2
SCHEMBL4617164 0.73 PPARG (0.73) PPARDPPARAPPARGLMNAMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039442-A1 Compounds With Kv4 Ion Channel Activity DEVGEN NV (BE) 2008-02-14 US claimed
EP-1838690-A2 COMPOUNDS WITH KV4 ION CHANNEL ACTIVITY Devgen N.V. (BE) 2007-10-03 EP claimed
WO-2006066879-A2 COMPOUNDS WITH KV4 ION CHANNEL ACTIVITY DEVGEN N.V. (BE) 2006-06-29 WO claimed
US-20080039442-A1 Compounds With Kv4 Ion Channel Activity DEVGEN NV (BE) 2008-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039442-A1 Compounds With Kv4 Ion Channel Activity KCNA4, HCN4, KCNN4 PPARD 3382/4885PPARA 3424/4885PPARG 3638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.